To date, several transcriptional co-activators have been reported to befrequently overexpressed in ESCC including deleted in breast cancer 1 (DBC1), p300, β-catenin, amplified in breast cancer 1 (AIB1) [9-13]. Here, CCAR2 is linked to esophageal squamous cell carcinoma.